Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 October 2021
EventHumanCOVID-19Vaccines
French is available via eTranslation, the European Commission's machine translation service.
Translate to French | Important information about machine translation
Date
- Lundi, 25 octobre 2021, Journée Entière
Lieu
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary plenary meeting is organised in the context of the evaluation of an application for the use of a booster dose for the COVID-19 vaccine Spikevax.
The aim of the meeting is to conclude this evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the Agency's opinions on all questions concerning human medicines.